 PARISBUSINESS WIREGenethon, a unique non-profit gene therapy RD organization founded by the French Muscular Dystrophy Association AFM-Telethon, has launched a pivotal clinical trial in Europe for treatment of Crigler-Najjar syndrome, a life threatening liver disease. The trial of the gene therapy, GNT-003, will be conducted in France, Italy and the Netherlands and will enroll patients ... Genethon Launches Pivotal Clinical Trial of Gene Therapy for... 